Endo to pay C$1.7 billion for Paladin Labs

7 November 2013 - Deborah Wilkes

Archived

Endo Health Solutions has agreed to acquire the Canadian prescription and OTC pharmaceutical company Paladin Labs in a deal worth C$1.7 billion (US$1.6 billion).

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: